Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Albuvirtide plus Kaletra in first-line failure HIV-1 infection
CTR20140177Phase 3Completed
- Sponsor
- Frontier Biotechnologies Inc.
- Start
- Mar 2014
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of albuvirtide in human immunodeficiency virus infection (HIV), acquired immunodeficiency syndrome (AIDS), sponsored by Frontier Biotechnologies Inc.. Started Mar 2014; status: completed.
02
Drugs
albuvirtide
03
Conditions
human immunodeficiency virus infection (HIV)acquired immunodeficiency syndrome (AIDS)
Beyond the preview
Go deeper on CTR20140177.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20140177.